[Evaluation of effect based on different typing methods in Escherichia coli]

Area of Science:

• Microbiology
• Genomics
• Molecular Typing

Background:

• Accurate molecular typing is crucial for understanding E. coli epidemiology and guiding clinical decisions.
• Traditional methods like serotyping and MLST have limitations in discriminatory power and resolution.
• CRISPR-Cas systems offer a unique genetic marker for bacterial typing.

Purpose of the Study:

• To evaluate the efficacy of CRISPRs typing for E. coli.
• To compare the discriminatory power of CRISPRs typing with serotyping and MLST.
• To assess the clinical applicability of CRISPRs-based typing.

Main Methods:

• CRISPRs spacer analysis using CRISPRsFinder.
• Serotyping using SeroTypeFinder.
• Multilocus Sequence Typing (MLST) for sequence type determination.
• PCR amplification of CRISPRs for spacer analysis.

Main Results:

• CRISPRs typing demonstrated the highest discriminatory power (Simpson index: 0.936) and correlation with serology (adjusted Rand index: 0.908).
• CRISPRs typing successfully subdivided common serotypes/STs into distinct subtypes.
• Accurate prediction of specific E. coli strains (e.g., O157:H7 ST11, ST131) was achieved using CRISPRs spacers.

Conclusions:

• CRISPRs spacer-based typing is a valuable and highly discriminatory molecular typing method for E. coli.
• This method shows significant potential for clinical applications in bacterial identification and epidemiology.
• CRISPRs typing complements and potentially surpasses traditional methods for E. coli characterization.